| Market revenue in 2024 | USD 1.8 million |
| Market revenue in 2030 | USD 4.8 million |
| Growth rate | 17.2% (CAGR from 2025 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, NGS Commercial Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
Several strategic initiatives have been undertaken in the country. In April 2022, Viafet Genomics Laboratory collaborated with Euformatics to provide carrier screening & clinical diagnostics in the UAE. Similarly, in November 2022, the Illumina Solutions Center in Dubai offered its services to scientists, medical professionals, and officials from the Emirate.
To enhance and provide precision medicine to patients, the new cutting-edge laboratory will increase genomics capabilities and develop local knowledge in the field. Illumina's most recent NGS and array technologies are located in a 9,100 square-foot solutions center.
Numerous clinical applications, including oncology, genetic disease testing, noninvasive prenatal testing, and quick diagnostic testing, can be performed with the equipment. Such initiatives are expected to boost the demand for NGS data analysis services in the near future.
Publish Date: Nov 10, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | www.pacb.com |
| DNAnexus | View profile | 101-250 | Mountain View, California, United States, North America | dnanexus.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Next-generation Sequencing Data Analysis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 66.67% in 2024.
Horizon Databook has segmented the Uae next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
Several strategic initiatives have been undertaken in the country. In April 2022, Viafet Genomics Laboratory collaborated with Euformatics to provide carrier screening & clinical diagnostics in the UAE. Similarly, in November 2022, the Illumina Solutions Center in Dubai offered its services to scientists, medical professionals, and officials from the Emirate.
To enhance and provide precision medicine to patients, the new cutting-edge laboratory will increase genomics capabilities and develop local knowledge in the field. Illumina's most recent NGS and array technologies are located in a 9,100 square-foot solutions center.
Numerous clinical applications, including oncology, genetic disease testing, noninvasive prenatal testing, and quick diagnostic testing, can be performed with the equipment. Such initiatives are expected to boost the demand for NGS data analysis services in the near future.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Next-generation Sequencing Data Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Next-generation Sequencing Data Analysis Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
